Literature DB >> 7245620

The intracellular distribution and antiviral activity of amantadine.

D D Richman, P Yazaki, K Y Hostetler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7245620     DOI： 10.1016/0042-6822(81)90614-0

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  9 in total

1.  Clinical significance and characterization of AZT-resistant strains of HIV-1.

Authors:  M A Wainberg; R Rooke; M Tremblay; X Li; M A Parniak; Q Gao; X J Yao; C Tsoukas; J Montaner; M Fanning; J Ruedy
Journal:  Can J Infect Dis       Date:  1991

2.  Tromantadine: inhibitor of early and late events in herpes simplex virus replication.

Authors:  K S Rosenthal; M S Sokol; R L Ingram; R Subramanian; R C Fort
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of amantadine hydrochloride.

Authors:  F Y Aoki; D S Sitar
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

4.  Conformational changes in Sindbis virus envelope proteins accompanying exposure to low pH.

Authors:  J Edwards; E Mann; D T Brown
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

5.  Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus.

Authors:  S Cassell; J Edwards; D T Brown
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

Review 6.  Antiviral chemotherapy and prophylaxis of viral respiratory disease.

Authors:  S J Sperber; F G Hayden
Journal:  Clin Lab Med       Date:  1987-12       Impact factor: 1.935

Review 7.  Early interactions between animal viruses and the host cell: relevance to viral vaccines.

Authors:  S Patterson; J S Oxford
Journal:  Vaccine       Date:  1986-06       Impact factor: 3.641

8.  Chapter 7 Orthomyxovirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29

9.  Chapter 3 Antiviral drugs: general considerations.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.